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     The present study seeks to evaluate the effects of Citrus aurantifolia peel essential oil on serum 
triglyceride and cholesterols in Wistar rats. Thirty Wistar rats were divided into 5 groups: control, 
sham, and 3 experimental groups. The animals were treated in 2 phases: first, except for control 
group, which received normal saline, the rest of the groups were fed with a high cholesterol regimen 
to induce hyperlipidemia; then, the 3 experimental groups were treated with Citrus aurantifolia peel 
essential oil in 3 different doses: 25, 50, and 100  lit/kg. Results: The sham group demonstrated a 
significant rise in mean serum triglyceride, cholesterol, and LDL level in comparison with the control 
group (p<0.05) proving the effectiveness of hypercholesterolemia induction. The results of 
experimental groups treated with peel essential oil in 50 and 100  lit/kg doses demonstrated a 
significant reduction in triglyceride, cholesterol, and LDL (p< 0.01). Application of the peel essential 
oil of Citrus aurantifolia showed significant decrease of cholesterol in rats in doses 50 and 100  
lit/kg. It is suggested that for cardiovascular risk reduction, the essential oil may be investigated for 
the same effects in human beings.  
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INTRODUCTION 
     Current predictions estimate that by the 
year 2020 cardiovascular diseases (CVD), 
particularly atherosclerosis, will become the 
leading global cause of total disease burden 
[1]. Recently, mortality caused by ischemic 
heart disease, comprise 7,063,000 deaths 
annually (12.6% of all causes of death), ranks 
first among the 10 leading causes of death 
world wide [2]. Ischemic heart disease itself, is 
caused by high serum cholesterol level. 
Hyperlipidemia represents a determinant for 
development of atherosclerosis and an 
important risk factor for cardiovascular disease 
[3] which is also the cause of 3,880,000 deaths 
annually throughout the world [2].  
      Considering the low rate of successful 
treatments, their high prices, and concerns on 
their availability, it has been suggested that the 
wise approach toward CVD is primary 
prevention and early treatment of 
hyperlipidemia [4]. This strategy seems to 
have been proven to be useful as the rate of 
CVD has increased in recent decades [4, 5]. 
      High serum triglyceride, a high level of 
LDL, and low serum HDL has proven to be 
associated with coronary artery disease [5]. 
Dyslipidemia, either primary (hereditary) or 
secondary (due to life style), is a modifiable 
risk factor [5 & 6] whose resolution reduces 
the total CVD risk score [7].  
     There is an undeniable tendency in the 
general population for herbal medicine and it 
is wise to direct this tendency toward major 
health problems if they prove to be effective. 
Citrus fruit peels have long been a source of 
herbal products especially in Chinese medicine 
[8]. In vitro studies indicate that the flavonoid 
component of citrus essential oil has 
cholesterol-lowering effects in cultured liver 
cells [9] and recent studies favor their effects 
in dyslipidemia both in animal studies and 
human clinical trials [10-14]. 
     In this study we treated previously induced 
dyslipidemia in rats with evaluating how the 
lipid profile might respond to this herbal 
essence. The ingredients of Citrus aurantifolia 
peel essential oil have been investigated to be 
limonene, alpha-terpineol, gama-terpinene, 
terpinolene, linalool and cineole [8]. 
  
MATERIALS AND METHOD 
      Thirty male Wistar rats were purchased 
from Pasteur Institute of Iran (Tehran, Iran) at 
6 weeks age. They were kept in animal room 
at 22-25 C temperature and were fed with 




commercial pellets until weighing 250-260g. 
They were randomly divided afterwards in to 5 
groups: experimental-1 (E-1), experimental-2 
(E-2), experimental-3 (E-3), sham and control 
group (n=6). The first 4 groups (E-1, E-2, E-3, 
and sham) received cholesterol (Merck Labs) 
for 4 weeks in two simultaneous ways: mixed 
with their daily pellet (2g cholesterol dissolved 
in 6 ml Oleic acid/100g pellet) and a separate 
diet of twice weekly (0.4 g dissolved in 1.2 ml 
Oleic acid) drip-fed. The Oleic acid was 
purchased from Merck Labs. The control 
group received a cholesterol-free diet and was 
force-fed with normal saline. After 4 weeks of 
cholesterol treatment, cholesterol was 
withdrawn from the diets. The E-1, E-2 and E-
3 experimental groups started to be force-fed 
with the Citrus aurantifolia of Rutacaea 
family peel essential oils (Barij Essence 
pharmaceutical Co., Kashan, Iran) for 6 
weeks, once daily, dissolved in distilled water, 
25  lit/kg, 50  lit/kg, and 100  lit/kg 
respectively (according to the information 
provided by provider). The sham group 
received normal saline once daily with the 
same method of experimental groups while the 
control group did not receive any treatment.  
      After the 70th day, the food was withheld 
for 12 h and the rats underwent general 
anesthesia by having them breathe evaporated 
diethyl ether in a closed chamber for 1 to 3 
minutes and blood samples were collected 
from the inferior vena cava with a 5 ml syringe 
carrying a 24 F needle. The rats were treated 
in this study according to The International 
Guiding Principles for Biomedical Research 
(1985). The serum was extracted from the 
centrifuged blood samples at 3000 rpm for 15 
minutes and the sera were kept in -4 C until 
analyzed. 
     Cholesterol (Chol), High Density 
Lipoprotein (HDL), and Low Density 
Lipoprotein (LDL), as well as TG (CPO-PAP), 
were all analyzed enzymatically (CHOD-PAP) 
using kits purchased from Pars Azmun Co 
(Tehran, Iran). 
      The results were analyzed using SPSS 16.0 
(SPSS Inc; Chicago, Illinois, USA). The 
descriptive results were reported as mean and 
standard deviation. In order to interpret the 
results differences between those in 
experimental groups and in sham and control 
groups, Kruskal Wallis test was used. Mann-
Whitney U test was applied to compare each 
experimental group with sham. The sham 
group and the control group were also 
compared using Mann-Whitney U test. P value 
was considered significant at < 0.05 level. 
 
RESULTS 
      The level of cholesterol (Chol), 
triglyceride (TG), high density lipoprotein 
(HDL), and low density lipoprotein (LDL) for 
each group is described in Table-1.  
Comparing the sham and the control groups, 
serum level of Cholesterol, TG, and LDL were 
markedly higher in the sham group (p<0.05), 
but the lower level of HDL in the sham group 
was not statistically significant.  
     Cholesterol and LDL levels were 
significantly lower in all experimental groups 
in comparison with the sham group. 
Triglyceride levels in all experimental groups 
were lower than that in the sham group; 
however, this difference was statistically 
significant only in E-2 and E-3 (p <0.01). 
Although the HDL levels were higher in all 
experimental groups both versus the shams 
and the controls, the result of Kruskal-Wallis 
test of heterogeneity in all 5 groups opposed 
this inference (p = 0.110). 
     The difference supposed to be made by the 
cholesterol regimen was first inspected in the 
results of the sham group whose variables 
were compared with those of the controls. This 
indicated that the cholesterol regimen had 
caused a significant rise in serum cholesterol, 
triglyceride and LDL, but this comparison did 
not show marked decrease in HDL mean value 
of the sham group. Then, results of all 
experimental groups (E-1, E-2, and E-3) were 
compared corresponding with variables in the 
sham group.  
     TG did not reduce significantly in the E-1 
group which was treated with 25  lit/kg of 
essential oils but the significant decrease was 
observed in TG, Cholesterol and LDL in the 
other two experimental groups which may 
reduce cardiovascular risk [7, 15]. 
 
CONCLUSION 
     The National Cholesterol Education 
Program (NCEP) in 2001 presented a 
guideline that a fall in HDL cholesterol 
less than 40 mg/dl HDL is a risk factor, 
but HDL cholesterol ≥ 60 mg/dl denotes a 
negative risk factor as it removes one risk 
factor for CVD from total scores [7]. In 
Kurowska's study the serum HDL 
decreased significantly in rabbits which 
had been given orange juice, but the 




decreased HDL level in rabbits given 
grapefruit juice was not significant [12]. 
Kurowska (2000) showed that human 
participants who took 750 ml/day orange 
juice showed significant increase in serum 
HDL cholesterol as much as 20%. Not 
only the HDL level in subjects of our 
study did not decrease, but showed a mild 
increase in experimental groups, and none 
of them was statistically significant.  
     Kurowska et al (2000) concluded that 4 
weeks treatment of mild-moderate 
hypercholesterolemic patients with 750 
ml/d of orange juice raises the HDL level 
and hence decreases LDL/HDL ratio [10]. 
Unlike the human study, orange juice 
decreases the LDL level in rabbits. 
     Kurowska et al (2000) postulated that 
incompatibility of the results in human and 
animal studies using the same substance 
with different results might be due to the 
low amount of the juice or its components 
consumed by the participants [10]. This 
rationale could be correct since the 
concentration of active components 
matters and reaching to effective dose of 
component by taking juices solely requires 
more than normal servings of orange juice, 
which could cause incompliance. This 
picture is not encountered in treatment 
with essential oils, as they are rich in 
active components and need not to be 
administered in large quantities to be 
effective. 
Cesar et al (2010), showed that consuming 
orange juice as a daily juice for 60 days 
(750 ml/d) could help hypercholestromic 
patients to decrease their risk factors of 
cardiovascular by reduction of LDL and 
cholesterol, but HDL and triglyceride 
remained unchanged, although free-
cholesterol transfer to HDL increased [16].  
      In conclusion, the effect of Citrus 
aurantifolia peel essential oil on the gross 
indicators of dyslipidemia seems 
promising in suggested doses of 50  lit/kg 
and 100  lit/kg, but further studies are 
required to evaluate the usefulness of this 
herbal essential oil in normal human and 
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